Janssen-Cilag International
www.janssen-cilag.com
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Janssen-Cilag International
Diurnal Renames Orphan Drug As Efmody, Expecting EU-Wide Approval
New treatments for congenital adrenal hyperplasia and relapsing forms of multiple sclerosis are among five drugs recommended for pan-EU approval this month. In addition, harmonized EU advice has been issued for Celltrion’s monoclonal antibody COVID-19 treatment.
EU Decision Time On Expanded Use Of BMS/Ipsen Pharma Cancer Drug Combo
The European Medicines Agency may decide this week on a dozen requests by companies seeking new uses of their approved drugs.
Sputnik V Vaccine Team ‘Working With EMA To Start Rolling Review’
After a few false starts, it seems that the EU regulator has begun preparing the ground for a review of Russia’s adenovirus-based COVID-19 vaccine.
EMA Starts Rolling Review Of CureVac’s COVID-19 Vaccine
CureVac has submitted the pre-clinical data package for its COVID-19 vaccine to the European Medicines Agency, which will be reviewing the data on a rolling basis.
Company Information
- Industry
- Pharmaceuticals